Mphasis reported a big miss on revenue with flat QoQ CC growth (vs. ISEC: +1.8%) and 0.1% QoQ USD (vs. ISEC: +1.9%; consensus: +2.1%) led by challenges in conversion of TCV to revenue, discretionary spend cuts, and continued challenge in DR business as well as BFS ex-DR. Deal TCV was soft at USD 255mn, down 16% YoY, partly due to higher conversion of pipeline to TCV in Q1FY24.